Decreased serum level of sphingosine‐1‐phosphate: a novel predictor of clinical severity in COVID‐19
Open Access
- 9 December 2020
- journal article
- research article
- Published by Springer Nature in EMBO Molecular Medicine
- Vol. 13 (1), e13424
- https://doi.org/10.15252/emmm.202013424
Abstract
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.Keywords
Funding Information
- Ministero della Salute (RC2020‐400)
This publication has 39 references indexed in Scilit:
- Corticosteroids Inhibit Sphingosine 1-Phosphate–Induced Interleukin-6 Secretion from Human Airway Smooth Muscle via Mitogen-Activated Protein Kinase Phosphatase 1–Mediated Repression of Mitogen and Stress-Activated Protein Kinase 1American Journal of Respiratory Cell and Molecular Biology, 2014
- Spns2, a transporter of phosphorylated sphingoid bases, regulates their blood and lymph levels, and the lymphatic networkThe FASEB Journal, 2012
- Fingolimod for Multiple SclerosisNew England Journal of Medicine, 2012
- Regulation of metabolism and transport of sphingosine-1-phosphate in mammalian cellsMolecular and Cellular Biochemistry, 2011
- Suppression of cytokine storm with a sphingosine analog provides protection against pathogenic influenza virusProceedings of the National Academy of Sciences, 2011
- Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein MProceedings of the National Academy of Sciences, 2011
- Vascular Endothelium As a Contributor of Plasma Sphingosine 1-PhosphateCirculation Research, 2008
- Infection and inflammation decrease apolipoprotein M expressionAtherosclerosis, 2007
- Erythrocytes store and release sphingosine 1‐phosphate in bloodThe FASEB Journal, 2007
- Correlation of high density lipoprotein (HDL)-associated sphingosine 1-phosphate with serum levels of HDL-cholesterol and apolipoproteinsAtherosclerosis, 2005